Stock DNA
Pharmaceuticals & Biotechnology
CNY 3,260 Million (Mid Cap)
11.00
NA
0.67%
0.06
7.79%
0.88
Revenue and Profits:
Net Sales:
896 Million
(Quarterly Results - Mar 2026)
Net Profit:
113 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.23%
0%
-15.23%
6 Months
-8.28%
0%
-8.28%
1 Year
19.49%
0%
19.49%
2 Years
58.22%
0%
58.22%
3 Years
0.78%
0%
0.78%
4 Years
-19.59%
0%
-19.59%
5 Years
-40.84%
0%
-40.84%
Allmed Medical Products Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-1.23%
EBIT Growth (5y)
-22.29%
EBIT to Interest (avg)
27.14
Debt to EBITDA (avg)
0.71
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
0.76
Tax Ratio
19.69%
Dividend Payout Ratio
36.30%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
16.52%
ROE (avg)
16.02%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
0.88
EV to EBIT
10.13
EV to EBITDA
6.61
EV to Capital Employed
0.89
EV to Sales
0.92
PEG Ratio
NA
Dividend Yield
0.67%
ROCE (Latest)
8.77%
ROE (Latest)
7.79%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
896.10
1,075.00
-16.64%
Operating Profit (PBDIT) excl Other Income
146.80
-38.80
478.35%
Interest
4.60
7.60
-39.47%
Exceptional Items
-8.00
2.80
-385.71%
Consolidate Net Profit
113.30
-97.70
215.97%
Operating Profit Margin (Excl OI)
163.80%
-92.90%
25.67%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -16.64% vs 16.81% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 215.97% vs -164.49% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
3,657.50
3,323.90
10.04%
Operating Profit (PBDIT) excl Other Income
807.60
665.80
21.30%
Interest
19.60
26.60
-26.32%
Exceptional Items
-258.60
-28.00
-823.57%
Consolidate Net Profit
257.10
368.80
-30.29%
Operating Profit Margin (Excl OI)
153.60%
130.40%
2.32%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 10.04% vs 21.43% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -30.29% vs 253.93% in Dec 2024
About Allmed Medical Products Co., Ltd. 
Allmed Medical Products Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






